Cytotoxic effect of dual fluorescent-labeled oncolytic herpes simplex virus type 1 on mouse tumorigenic cell lines
The increasing incidences of cancer at the global scale have recently resulted in the invention of various biotechnology approaches among which the oncolytic virotherapy is a new strategy for the treatment of multiple tumors. Herpes simplex virus (HSV) based vectors are one of the most studied oncol...
Saved in:
Main Authors: | Shahriyar Abdoli (Author), Farzin Roohvand (Author), Ladan Teimoori-Toolabi (Author), Sara Shayan (Author), Mohammad Ali Shokrgozar (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Presage of oncolytic virotherapy for oral cancer with herpes simplex virus
by: Yoshiaki Yura
Published: (2017) -
Oncolytic Herpes Simplex Viral Therapy: A Stride toward Selective Targeting of Cancer Cells
by: Dhaval S. Sanchala, et al.
Published: (2017) -
Oncolytic herpes simplex virus tumor targeting and neutralization escape by engineering viral envelope glycoproteins
by: Xiao-Qin Liu, et al.
Published: (2018) -
Antitumor effects of oncolytic herpes simplex virus type 2 against colorectal cancer in vitro and in vivo
by: Yin L, et al.
Published: (2017) -
Dual-Labelled Nanoparticles Inform on the Stability of Fluorescent Labels In Vivo
by: Sabrina Roussel, et al.
Published: (2023)